71413-82-6Relevant academic research and scientific papers
New compounds having skin whitening, antioxidant and PPAR activity, and medical use thereof
-
Paragraph 0498-0499; 0505, (2017/04/14)
PURPOSE: A novel compound with skin whitening, antioxidation, and PPAR activation effects, and a medical use thereof are provided to be used for a pharmaceutical composition or a cosmetic product. CONSTITUTION: A compound is denoted by chemical formula 1. A skin whitening composition contains the compound as an active ingredient. An antioxidative composition for preventing or treating oxidative diseases contains the compound of chemical formula 1 as an active ingredient. The oxidative diseases are selected among skin aging, pigmentation, wrinkling, psoriasis, or eczema. The composition prevents or treats diseases which are regulated by PPAR(peroxisome proliferator-activated receptor) activity. The PPAR includes PPAR alpha or PPAR gamma.
NOVEL COMPOUND HAVING SKIN-WHITENING, ANTI-OXIDIZING AND PPAR ACTIVITIES AND MEDICAL USE THEREFOR
-
Paragraph 0312-0313; 0316, (2014/02/16)
Provided are a novel compound having skin-whitening, anti-oxidizing and PPAR activities and a medical use thereof, and the compound has skin-whitening activities for the suppression of tyrosinase, and accordingly, is useful for use in skin-whitening pharmaceutical composition or cosmetic products; has anti-oxidant activities, and accordingly, is useful for the prevention and treatment of skin-aging; and has PPAR activities, and in particular, PPARα and PPARγ activities, and accordingly, is useful for use in pharmaceutical compositions or health foods which are effective for the prevention and treatment of obesity, metabolic disease, or cardiovascular disease.
Synthesis and antibacterial activity of certain fused azoles and oxazinones
El-Saghier, Ahmed M.,Alwedi, Embarak F.,Fawzy, Naglaa M.
experimental part, p. 664 - 668 (2012/09/07)
2-Phenyl-4-benzylidene-5(4H)-oxazolones (1a-e) were used as versatile starting materials for the synthesis of fused compounds such as: 4H-3,1-benoxazin-4-ones (2a,b), imidazo[4,3-b]benzimidazoles (3,4), imidazo[1,5-b]1,2,4-triazoles (5a,b), and 7.
A modified synthesis of (±)-β-aryllactic acids
Wong,Xu,Chang,Lee
, p. 793 - 797 (2007/10/02)
The synthesis of racemic forms of the reportedly active principle of Danshen, namely (±)-β-(3,4-dihydroxyphenyl)lactic acid [(±)3-(3,4-dihydroxyphenyl)-2-hydroxypropanoic acid] and its seven racemic derivatives is reported.
Process for the preparation of l-dopa
-
, (2008/06/13)
The present invention is directed to preparing L-Dopa, an agent effective in the treatment of Parkinson's Disease, from a D,L-N-benzoyl-3-(4-hydroxy-3-methoxyphenyl) alanine utilizing dehydroabietylamine as a resolving agent and intermediates in this proc
